Emerging Stocks Down Under 31 May 2022: Chrysos (ASX:C79)

Emerging Stocks Down Under 31 May 2022: Chrysos (ASX:C79) 2
Chrysos: Poorly timed listing or legitimate concerns?
Every now and then, one of the CSIRO’s inventions gets spun out of the public service and onto the public markets. While typically these are medical or agriculture-focused spin outs, Chrysos’ (ASX: C79) technology focuses on the resources sector. Its PhotonAssay units are essentially high-powered X-rays that process rock samples for gold and other metals. Mr. Market has not been a fan of the company since it listed a few weeks ago sending it down from $6.50 to as low as $3.77. But did the company just time its ASX listing poorly, or should investors genuinely be concerned about the company? Click here to read the previous edition of Emerging Stocks Down Under published 24 May 2022 For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter.
Please register or upgrade your plan to access this content.

Save $$$
30-Day Free Trial
$0
No Credit Card Required!
Get access to 5 publications per week
Weekly Investor Webinar
Profit Premium
$69
Get access to 5 publications per week
Access to the full research Archive
Weekly Investor Webinar
30-Day Free Trial
$0
No Credit Card Required!
Get access to 5 publications per week
Weekly Investor Webinar
Profit Premium
$59
BILLED ANNUALLY
Get access to 5 publications per week
Access to the full research Archive
Weekly Investor Webinar